Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent

201461 citationsJournal Articlegold Open Access

Authors

Jodi R. Alt · Sage Technologies (United States)

Bradford A. Hunsley · Sage Technologies (United States)

M Fernando · Sage Technologies (United States)

Abstract

Cell-Free DNA™ BCT blood collection device preserves and stabilizes CTCs in blood samples for at least 4 days at RT. This technology may facilitate the development of new non-invasive diagnostic and prognostic methodologies for CTC enumeration as well as characterization.

Topics & Keywords

Cancer Cells and Metastasis Cancer Genomics and Diagnostics Microfluidic and Bio-sensing Technologies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer Cell International

Volume 14, Issue 1, pp. 23-23

DOI: 10.1186/1475-2867-14-23

Field-Weighted Citation Impact: 2.54